5.64
Schlusskurs vom Vortag:
$5.67
Offen:
$5.69
24-Stunden-Volumen:
2.08M
Relative Volume:
0.75
Marktkapitalisierung:
$752.43M
Einnahmen:
$3.24B
Nettoeinkommen (Verlust:
$-66.64M
KGV:
-10.63
EPS:
-0.5308
Netto-Cashflow:
$219.38M
1W Leistung:
-1.05%
1M Leistung:
+0.89%
6M Leistung:
-52.61%
1J Leistung:
-36.98%
Adapthealth Corp Stock (AHCO) Company Profile
Firmenname
Adapthealth Corp
Sektor
Branche
Telefon
610-424-4515
Adresse
555 EAST NORTH LANE, CONSHOHOCKEN, PA
Compare AHCO vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
AHCO
Adapthealth Corp
|
5.64 | 752.43M | 3.24B | -66.64M | 219.38M | -0.5308 |
|
ABT
Abbott Laboratories
|
98.83 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
86.29 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
275.39 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
43.65 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.32 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Adapthealth Corp Stock (AHCO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-08 | Herabstufung | Jefferies | Buy → Hold |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-05-10 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-05-10 | Herabstufung | Stifel | Buy → Hold |
| 2023-05-09 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-03-18 | Eingeleitet | Truist | Buy |
| 2021-01-26 | Eingeleitet | BofA Securities | Buy |
| 2020-12-10 | Eingeleitet | UBS | Buy |
| 2020-08-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-07-01 | Fortgesetzt | SVB Leerink | Outperform |
| 2020-06-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-01-31 | Eingeleitet | Stifel | Buy |
| 2020-01-07 | Eingeleitet | Jefferies | Buy |
| 2019-12-11 | Eingeleitet | SVB Leerink | Outperform |
| 2019-12-10 | Eingeleitet | Deutsche Bank | Buy |
Alle ansehen
Adapthealth Corp Aktie (AHCO) Neueste Nachrichten
AdaptHealth Corp. (AHCO) Stock Forecasts - Yahoo! Finance Canada
AdaptHealth Corp. (AHCO) Stock Price, News, Quote & History - Yahoo! Finance Canada
AdaptHealth Names Currie CFO as Growth Push Takes Shape - MyChesCo
Adapthealth Stock Price Forecast. Should You Buy AHCO? - StockInvest.us
AdaptHealth Class Action Reminder - TMX Newsfile
AHCO Maintained by Baird -- Price Target Lowered to $9.00 - GuruFocus
AHCO Q2 2026 Earnings: EPS Misses Estimates by 48% Yet Shares Edge HigherPre-Earnings Setup - careplusvn.com
3 Reasons AHCO is Risky and 1 Stock to Buy Instead - Yahoo Finance
Currie Harriss T Awarded 141,372 Shares of AdaptHealth Corp, Establishing New Insider Stake - Kalkine Media
AdaptHealth CFO Harriss T. Currie Granted 141,372 Restricted Stock Units - Kalkine Media
AdaptHealth To Participate in Upcoming Investor Conferences - Yahoo Finance
Truist reiterates Buy on AdaptHealth stock after CFO change By Investing.com - Investing.com South Africa
AdaptHealth Data Breach Affects 4.1 Million Individuals - The HIPAA Journal
People on the Move: Harriss Currie Named Chief Financial Officer of AdaptHealth - BioBuzz
Why AdaptHealth (AHCO) Stock Is Down Today - finance.yahoo.com
AdaptHealth (NASDAQ: AHCO) Appoints Harriss Currie as CFO with $670,000 Salary and $818K in Stock Units - Kalkine Media
Truist reiterates Buy on AdaptHealth stock after CFO change - investing.com
Price-Driven Insight from (AHCO) for Rule-Based Strategy - Stock Traders Daily
AdaptHealth appoints new chief financial officer Currie - The Globe and Mail
AdaptHealth Names Chief Financial Officer - marketscreener.com
AdaptHealth (AHCO) taps new CFO with $670,000 salary - Stock Titan
AdaptHealth names Harriss Currie as chief financial officer - investing.com
AdaptHealth names Harriss Currie as chief financial officer By Investing.com - Investing.com India
A new finance chief takes over Sept. 9; the current CFO helps through Oct. 1 at AdaptHealth. - Stock Titan
AdaptHealth sets Q2FY26 earnings release date for August 4 - scanx.trade
AdaptHealth Corp. (AHCO) Jumps 6.29% to $6.42 — Potential Push Toward $6.74 ResistanceVolume Gap - careplusvn.com
Senior Health, Home Health & Hospice Stocks Q2 Recap: Benchmarking AdaptHealth (NASDAQ:AHCO) - Yahoo Finance
AdaptHealth Tries To Reset After A Tough 2026 - Finimize
Responsive Playbooks and the AHCO Inflection - Stock Traders Daily
Grabar Law Office Investigates Claims on Behalf of Long-term Shareholders of Adapthealth Corp. (AHCO) as Securities Fraud Class Case Heads to Settlement Mediation - TMX Newsfile
AdaptHealth Wins First OK For $14.3M NC Overbilling Deal - Law360
Bronstein, Gewirtz & Grossman, LLC Encourages AdaptHealth Corp. (AHCO) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth C - The National Law Review
AdaptHealth (NASDAQ:AHCO) Faces Pressure After Weak Quarterly Results - kalkinemedia.com
AdaptHealth breach exposed health records of one in 13 Vermonters - Vermont Daily Chronicle
AdaptHealth Breach Exposed Health Records of One in 13 Vermonters - Compass Vermont
AdaptHealth Corp. (NASDAQ:AHCO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
AdaptHealth (AHCO) Closing Note: Falls 1.12% to $5.75 in the Current Update; Boundary Check - Vinanet
AdaptHealth's Market Cap Drops To US$696m Leaving Insiders With Losses - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AdaptHealth Corp. (AHCO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
AdaptHealth Corp. (AHCO) Q2 2026 Earnings: EPS Misses Estimates by 48.1% on Unreported RevenueNet Profit Margin - vinanet.vn
2026-08-16 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AdaptHealth Corp. (AHCO) and Encourages Investors to Learn More About the Investigation | NDAQ:AHCO | Press Release - Stockhouse
AdaptHealth (NASDAQ:AHCO) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
AdaptHealth Corp. (AHCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of ... - Caledonian Record
AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information - GlobeNewswire
AdaptHealth Director Dale B. Wolf Updates Stock Purchase Price in Amended SEC Filing - Kalkine Media
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Investors to Connect - ACCESS Newswire
Kenneth Samet Bought 94% More Shares In AdaptHealth - webull.com
5 Must-Read Analyst Questions From AdaptHealth’s Q2 Earnings Call - Yahoo Finance
Finanzdaten der Adapthealth Corp-Aktie (AHCO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Adapthealth Corp-Aktie (AHCO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| WOLF DALE B | Director |
Aug 06 '26 |
Buy |
6.37 |
20,000 |
127,400 |
143,234 |
| WOLF DALE B | Director |
Aug 07 '26 |
Buy |
5.86 |
20,000 |
117,200 |
34,000 |
| Schuster III Russell E. | Chief Commercial Officer |
Jul 01 '26 |
Sale |
10.44 |
11,275 |
117,711 |
125,263 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):